There were 149 press releases posted in the last 24 hours and 425,914 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Data from 223-Patient Phase 2b Clinical Trial of Galera Therapeutics’ GC4419 Presented at 2018 American Society of Clinical Oncology (ASCO) Annual Meeting

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image